Jump to content

Recommended Posts

alanbarlee

The European Society for Medical Oncology (ESMO) has just had its Annual Conference in Copenhagen.

 

Click here and here for 2 reports from Practice Update about some of the things discussed at ESMO 2016 and the implications for patients.

 

 

Link to post
Share on other sites

My doctors have differing views about the Chaarted Trial.

 

One of my docs advised foregoing chemo for my one bone met and just doing Zytiga/Lupron plus spot radiation. However, two other two docs said to add the chemo -- so now I get to choose!
 
As reported in biosciencetechnology, a Harvard University and Waterloo University team has found that a common breast cancer chemotherapy can create stem-like cancer cells out of more differentiated tumor cells.   This change in the nature of the tumour cells might be another downside to early chemo with ADT.

 

Link to post
Share on other sites
×
×
  • Create New...